ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation (ROCO)

August 23, 2021 updated by: University of Bern

Randomized Controlled Trial (RCT) to Evaluate the Efficacy of an Internet-based Self-help Program for People With Psychological Distress Due to Covid-19

As part of the ROCO project, the University of Bern is investigating an online self-help program for people who are psychologically distressed due to the situation surrounding Covid-19. The ROCO program offers support in overcoming this psychological distress. ROCO stands for a 3-week online self-help program comprising 6 modules.

The aim of the study is to investigate the efficacy of an online self-help intervention for people with psychological distress due to the situation surrounding Covid-19. All participants will be randomized to one of two groups: The first group receives direct access to the online self-help intervention and the second group is a waiting control group that receives access to the program 3 weeks later. In both conditions additional care or treatment is allowed.

There are 4 assessments, which all take place online: baseline, post assessment (after 3 weeks) and two follow-up assessments (after 6 and 18 weeks). All participants from both groups are asked to fill out all assessments.

Study Overview

Study Type

Interventional

Enrollment (Actual)

107

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bern, Switzerland, 3012
        • Universität Bern

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be at least 18 years old
  • Give a declaration of consent to participate in the study
  • Have access to the internet
  • Understand and master the German language to the degree that they understand the contents and instructions of the study
  • Exceed a cut-off value of 4 points on the Brief Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog, 2002)
  • Be able to specify an emergency address in the event of an acute crisis

Exclusion Criteria:

  • Suicidal tendencies (SBQ-R Score ≥ 8)
  • Existence of a known diagnosis of a psychotic or bipolar disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Internet-based self-help
The self-help program consists of six text- and video-based modules. All participants in this group receive immediate access to the self-help program. The program's self-management approach does not provide for regular support from a specialist. However, participants can contact the study team if they need or want additional help.
Six cognitive-behavioral, mindfulness and acceptance commitment based modules focusing on different aspects of psychological distress due to the Covid-19 situation.
Other: Waiting control group
Access to internet-based intervention after 3 weeks.
Six cognitive-behavioral, mindfulness and acceptance commitment based modules focusing on different aspects of psychological distress due to the Covid-19 situation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire (Löwe et al., 2002)
Time Frame: up to 18 weeks
9-item questionnaire assessing depressive symptoms
up to 18 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Suicide Behavior Questionnaire Revised (Glaesmer et al., 2018)
Time Frame: up to 18 weeks
4-item questionnaire assessing suicidal ideation
up to 18 weeks
DASS-21: Depression, Angst, Stress-Skala (Lovibond & Lovibond, 1995)
Time Frame: up to 18 weeks
21-item questionnaire assessing depression, anxiety and stress symptoms
up to 18 weeks
SF-12: Short Form Health Survey (Ware et al., 1996)
Time Frame: up to 18 weeks
12-item questionnaire assessing various aspects of well-being
up to 18 weeks
LOT-R: Revised Life Orientation Test (Herzberg et al., 2006)
Time Frame: up to 18 weeks
10-item questionnaire assessing optimism and pessimism
up to 18 weeks
Berner Verbitterungsinventar Kurzversion (Znoj, 2008)
Time Frame: up to 18 weeks
6-item questionnaire assessing embitterment
up to 18 weeks
Emotion regulation skills SEK-27 (Berking & Znoj, 2008)
Time Frame: up to 18 weeks
27-item questionnaire assessing emotion regulation skills
up to 18 weeks
SWE: Skala zur Allgemeinen Selbstwirksamkeit (Jerusalem & Schwarzer, 2003)
Time Frame: up to 18 weeks
10-item questionnaire assessing general self-efficacy
up to 18 weeks
UCLA Loneliness Scale (Döring & Bortz, 1993)
Time Frame: up to 18 weeks
9-item questionnaire assessing loneliness
up to 18 weeks
Connor-Davidson Resilience Scale (Sarubin et al., 2015)
Time Frame: up to 18 weeks
10-item questionnaire assessing resilience
up to 18 weeks
ZUF-8: Zufriedenheitsfragebogen (Attkisson & Zwick, 1982)
Time Frame: at 3 weeks for experimental group and at 6 weeks for waiting control group
8-item questionnaire assessing content with an online-program
at 3 weeks for experimental group and at 6 weeks for waiting control group
SUS: System Usability Scale (Brooke, 1996)
Time Frame: at 3 weeks for experimental group and at 6 weeks for waiting control group
10-item questionnaire assessing usability of an online-program
at 3 weeks for experimental group and at 6 weeks for waiting control group

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Hansjörg Znoj, Prof. Dr., University of Bern

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 6, 2020

Primary Completion (Actual)

July 29, 2021

Study Completion (Actual)

July 29, 2021

Study Registration Dates

First Submitted

May 7, 2020

First Submitted That Met QC Criteria

May 7, 2020

First Posted (Actual)

May 8, 2020

Study Record Updates

Last Update Posted (Actual)

August 24, 2021

Last Update Submitted That Met QC Criteria

August 23, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Distress

Clinical Trials on Internet-based self-help

3
Subscribe